z-logo
Premium
Therapeutic potential of histamine H 4 receptor agonists in triple‐negative human breast cancer experimental model
Author(s) -
Martinel Lamas Diego J,
Croci Maximo,
Carabajal Eliana,
Crescenti Ernesto J V,
Sambuco Lorena,
Massari Noelia A,
Bergoc Rosa M,
Rivera Elena S,
Medina Vanina A
Publication year - 2013
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/bph.12137
Subject(s) - histamine , breast cancer , apoptosis , medicine , proliferating cell nuclear antigen , cancer , endocrinology , receptor , mammary gland , histamine h4 receptor , cancer research , immunology , pathology , biology , histamine h2 receptor , immunohistochemistry , antagonist , biochemistry
The presence of the histamine H₄ receptor (H₄R) was previously reported in benign and malignant lesions and cell lines derived from the human mammary gland. The aim of this work was to evaluate the effects of H₄R ligands on the survival, tumour growth rate and metastatic capacity of breast cancer in an experimental model.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here